Literature DB >> 12110429

Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture.

F C den Boer1, J A M Bramer, T J Blokhuis, E J Van Soest, J M G T Jenner, P Patka, F C Bakker, E H Burger, H J T M Haarman.   

Abstract

Osteogenic protein-1 (OP-1), or bone morphogenetic protein-7, is an osteoinductive morphogen that is involved in embryonic skeletogenesis and in bone repair. In bone defect models without spontaneous healing, local administration of recombinant human OP-1 (rhOP-1) induces complete healing. To investigate the ability of rhOP-1 to accelerate normal physiologic fracture healing, an experimental study was performed. In 40 adult female goats a closed tibial fracture was made, stabilized with an external fixator, and treated as follows: (1) no injection; (2) injection of 1 mg rhOP-1 dissolved in aqueous buffer; (3) injection of collagen matrix; and (4) injection of 1 mg rhOP-1 bound to collagen matrix. The test substances were injected in the fracture gap under fluoroscopic control. At 2 and 4 weeks, fracture healing was evaluated with radiographs, three-dimensional computed tomography (CT), dual-energy X-ray absorptiometry, biomechanical tests, and histology. At 2 weeks, callus diameter, callus volume, and bone mineral content at the fracture site were significantly increased in both rhOP-1 groups compared with the no-injection group. As signs of accelerated callus maturation, bending and torsional stiffness were higher and bony bridging of the fracture gap was observed more often in the group with rhOP-1 dissolved in aqueous buffer than in uninjected fractures. Treatment with rhOP-1 plus collagen matrix did not result in improved biomechanical properties or bony bridging of the fracture gap at 2 weeks. At 4 weeks there were no differences between groups, except for a larger callus volume in the rhOP-1 plus collagen matrix group compared with the control groups. All fractures showed an advanced stage of healing at 4 weeks. In conclusion, the healing of a closed fracture in a goat model can be accelerated by a single local administration of rhOP-1. The use of a carrier material does not seem to be crucial in this application of rhOP-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110429     DOI: 10.1016/s8756-3282(02)00816-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

1.  Recombinant human BMP-7 grafted poly(lactide-co-glycolide)/hydroxyapatite scaffolds via polydopamine for enhanced calvarial repair.

Authors:  Qinli Xu; Ye Li; Yuhang Zhu; Kunchi Zhao; Rui Gu; Qingsan Zhu
Journal:  RSC Adv       Date:  2018-07-31       Impact factor: 4.036

2.  Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.

Authors:  Bo Yi Kim; Soo Hyun Choi; Ji-Young Kim; JaeSang Ko; Jong In Yook; Hyun Sil Kim; Eun Jig Lee; Don O Kikkawa; Jin Sook Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

3.  Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function.

Authors:  Elise F Morgan; Zachary D Mason; Karen B Chien; Anthony J Pfeiffer; George L Barnes; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Bone       Date:  2008-10-25       Impact factor: 4.398

4.  Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience.

Authors:  Bruno Dohin; Noémi Dahan-Oliel; François Fassier; Reggie Hamdy
Journal:  Clin Orthop Relat Res       Date:  2009-07-09       Impact factor: 4.176

5.  Recombinant human bone morphogenetic protein-7 enhances fracture healing in an ischemic environment.

Authors:  Chuanyong Lu; Zhiqing Xing; Yan-yiu Yu; Celine Colnot; Theodore Miclau; Ralph S Marcucio
Journal:  J Orthop Res       Date:  2010-05       Impact factor: 3.494

6.  Constructing the toolbox: Patient-specific genetic factors of altered fracture healing.

Authors:  Hicham Drissi; David N Paglia; Farhang Alaee; Ryu Yoshida
Journal:  Genes Dis       Date:  2014-12-01

Review 7.  Bone Regeneration Using Bone Morphogenetic Proteins and Various Biomaterial Carriers.

Authors:  Zeeshan Sheikh; Mohammad Ahmad Javaid; Nader Hamdan; Raheel Hashmi
Journal:  Materials (Basel)       Date:  2015-04-15       Impact factor: 3.623

8.  Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures.

Authors:  Neil Ghodadra; Kern Singh
Journal:  Biologics       Date:  2008-09

Review 9.  Supramolecular self-assembling peptides to deliver bone morphogenetic proteins for skeletal regeneration.

Authors:  Charlotte H Chen; Erin L Hsu; Samuel I Stupp
Journal:  Bone       Date:  2020-07-31       Impact factor: 4.398

10.  Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1.

Authors:  Thomas Maurer; Gerald Zimmermann; Susanne Maurer; Sabine Stegmaier; Christof Wagner; G Maria Hänsch
Journal:  Mediators Inflamm       Date:  2012-10-24       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.